2016 International Congress Archives - Page 148 of 207

Postural and nonmotor disturbances in Parkinson’s disease

A. Pilipovich, V. Golubev, G. Ptimat (Moscow, Russia)
Potential advantages of high resolution lead designs for deep brain stimulation

J. Wu, M. Astrom, G. Molnar (Minneapolis, MN, USA)
Pre-formed fibrils injection worsen pathology caused by AAV-mediated over expression of α-synuclein

L.S. Breger, P. Thakur, O.W. Wan, B. Mattsson, K. Luk, V.M. Lee, J. Trojanowski, A. Björklund (Lund, Sweden)
Pre-pulse inhibition of blink reflex in cervical dystonia

M. Kiziltan, O. Öztürk, A. Gündüz (Istanbul, Turkey)
Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?

T. Falk, M.J. Bartlett, T. Ye, L.B. Lazarus, M.L. Heien, S.L. Cowen, S.J. Sherman (Tucson, AZ, USA)
Predicting incident impulse control disorder behaviour in Parkinson’s disease patients using a clinical-genetic model

J. Kraemmer, K. Smith, D. Weintraub, V. Guillemot, M.A. Nalls, F. Cormier, I. Moszer, A. Brice, A.B. Singleton, J.C. Corvol (Paris, France)
Predicting medication reduction in Parkinson’s disease patients after deep brain stimulation

S.A. Dodwell, C.E. Ashton, D.K. Simon, D. Tarsy, E. Papavassiliou, R. Alterman, L. Shih (Boston, MA, USA)
Predicting poor functional outcome in Parkinson’s disease

A.D. Macleod, C.E. Counsell (Aberdeen, United Kingdom)
Predicting risk of sarcopenia in people with Parkinson’s disease

A.P.C. Loureiro, B. Yamaguchi, I.L.P. Villegas, M.P. Ferreira, V.L. Israel (Curitiba, Brazil)
Predicting therapeutic effects of atomoxetine and citalopram on response inhibition in Parkinson’s disease

J.B. Rowe, C. Rae, C. Nombela, T. Ham, P. Vazquez, I. Coyle-Gilchrist, C.R. Housden, B.J. Sahakian, T.W. Robbins, Z. Yes (Cambridge, United Kingdom)